Avatar-Based Serious Game for Cardiac Rehabilitation After Heart Attack
Effectiveness of an Avatar-Based Serious Game in Facilitating Transition to Cardiac Rehabilitation After Myocardial Infarction: A Randomized Controlled Trial
This study looks at whether a tablet-based education game helps people recover better after a heart attack. When people leave the hospital after a heart attack, they are usually given advice about their medicines, follow-up visits, cardiac rehabilitation, and warning signs to watch for. Many people find it hard to remember all of this information later at home.
In this study, adults who were treated in hospital for a heart attack were divided by chance into two groups. One group received the usual face-to-face education before going home. The other group used an interactive avatar-based education game on a tablet, in which a guide character walks the patient through the same topics. The game could also be used at home for one month after discharge.
The researchers measured how much patients knew about their heart disease, their quality of life, whether they attended cardiac rehabilitation, and whether they were readmitted to hospital. These were checked before discharge and again at 1, 3, and 6 months. The goal is to learn whether the avatar-based game helps patients understand and manage their condition better than usual education.
調査の概要
状態
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Isparta、トルコ（Türkiye）
- Suleyman Demirel University
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Confirmed ST-elevation or non-ST-elevation myocardial infarction during the current admission or within the preceding three months, including patients readmitted for revascularization (percutaneous coronary intervention or coronary artery bypass grafting)
- Planned discharge to home
- Able to operate a tablet computer or a smart phone
- Provided written informed consent
Exclusion Criteria:
- Insufficient Turkish-language proficiency to engage with the application or study procedures
- Severe comorbidity precluding engagement in lifestyle behaviour change or exercise
- Significant cognitive or visual impairment
- Concurrent enrolment in another interventional study
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：対照群
|
Standard face-to-face discharge education delivered individually by the principal investigator before discharge, covering medication management, personal health record keeping, follow-up continuity and cardiac rehabilitation, and recognition of warning signs.
|
|
実験的：Avatar-based education group
|
Tablet-based, avatar-guided discharge education application structured around Coleman's Care Transitions Intervention model (medication management, personal health record, follow-up continuity, and recognition of warning signs), delivered through interactive, persona-adapted, scenario-based gameplay before discharge and accessible for one month afterwards.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Coronary artery disease knowledge (CADE-Q II)
時間枠：Post-intervention and at 1, 3, and 6 months after discharge
|
Disease-related knowledge measured with the Coronary Artery Disease Education Questionnaire II (CADE-Q II), a 31-item instrument scored 0-93, with higher scores indicating greater knowledge.
|
Post-intervention and at 1, 3, and 6 months after discharge
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Health-related quality of life (HeartQoL)
時間枠：Post-intervention and at 1, 3, and 6 months after discharge
|
Disease-specific health-related quality of life measured with the HeartQoL questionnaire (14 items, total score 0-42), with higher scores indicating better quality of life.
|
Post-intervention and at 1, 3, and 6 months after discharge
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- doi.org/10.1093/ehjdh/ztaf036
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。